InsidersTradesSigma
Track the 오션스바이오 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 오션스바이오 has published 2 insider filings. The latest transaction was reported on 1 April 2026 (Purchase). Among the most active insiders: 캡스톤파트너스. The full history is openly available.
2
Insider Decl.
n/a
Thresholds
n/a
2 ops.
Buy Volume
n/a
n/a
Sell Volume
2Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 April 2026
Acerca de 오션스바이오
Oceans Bio está en el sector de la salud y farmacéutico, cotizando en el mercado XKRX. La empresa se enfoca en el desarrollo de soluciones biológicas innovadoras.